You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Estrogen Receptors

Showing 1 - 25 of 3,375
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Arterial Hypertension Trial in Nashville (ESR-specific PET scan)

Recruiting
  • Pulmonary Arterial Hypertension
  • ESR-specific PET scan
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 26, 2022

Skin Tear, Estrogen Deficiency Trial in Roma (Blood sampling, Shave Biopsy)

Not yet recruiting
  • Skin Tear
  • Estrogen Deficiency
  • Blood sampling
  • Shave Biopsy
  • Roma, Italy
    University La Sapienza of Rome
Aug 11, 2020

Breast Cancer Trial in Saint Louis (18F-FFNP, CTI/Siemens Biograph 40 PET/CT Scanner, Estradiol)

Completed
Has Results
  • Breast Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 13, 2020

FES TEP in Detection of Estrogen Receptors Trial in Dijon (FES PET)

Unknown status
  • FES TEP in Detection of Estrogen Receptors
  • FES PET
  • Dijon, France
    CGFL
Oct 25, 2019

Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

Recruiting
  • Breast Cancer
  • +2 more
    • Wuhan, Hubei, China
      TongjiHospital
    Sep 12, 2022

    Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Springfield, Massachusetts
    • +2 more
    Nov 1, 2022

    Clomiphene Citrate asInhibitor of Ovulation inOocyte

    Not yet recruiting
    • Infertility, Female
    • Infertility
    • Baton Rouge, Louisiana
      Womans Hospital
    May 17, 2023

    Endometriosis Trial in New Haven (simvastatin 10mg, Bazedoxifene 20/Estrogens,Con 0.45Mg Tb, Placebo)

    Recruiting
    • Endometriosis
    • simvastatin 10mg
    • +2 more
    • New Haven, Connecticut
      The John B. Pierce Laboratory
    Dec 8, 2022

    Purinergic Signaling and the Postmenopausal Heart

    Recruiting
    • Diastolic Heart Failure
    • Heart Failure With Preserved Ejection Fraction
    • Gender
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Aug 28, 2023

    Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 13, 2023

    Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia

    Not yet recruiting
    • Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
    • identify biomarkers
    • (no location specified)
    May 13, 2023

    Muscle, Fat and Tissue Receptors

    Active, not recruiting
    • Gender Incongruence
    • Transgenderism
    • testosterone cypionate
    • Estradiol Valerate
    • Saint Louis, Missouri
      Saint Louis Univeristy
    Jan 13, 2023

    Molecular Signature for Breast Cancer

    Not yet recruiting
    • Breast Cancer
    • Diagnostic assistance tool
    • (no location specified)
    Feb 2, 2023

    Frozen Embryo Transfer, Infertility, Female Trial in Udaipur (17-beta Estradiol gel 0.06% w/w(ESTOGEL.Intas pharma), Estradiol

    Not yet recruiting
    • Frozen Embryo Transfer
    • Infertility, Female
    • 17-beta Estradiol gel 0.06% w/w(ESTOGEL.Intas pharma)
    • Estradiol Hemihydrate(Estrabet Tablet, abbott pharma)
    • Udaipur, Rajasthan, India
      Indira IVF Hospital Private Limited
    Apr 4, 2023

    Advanced Malignant Tumor Trial in Guangzhou, Zhengzhou, Nanjing (TQB3915 tablets)

    Recruiting
    • Advanced Malignant Tumor
    • TQB3915 tablets
    • Guangzhou, Guangdong, China
    • +2 more
    Jun 9, 2022

    Breast Cancer Female Trial in Clermont-Ferrand (blood samples collection)

    Recruiting
    • Breast Cancer Female
    • blood samples collection
    • Clermont-Ferrand, Puy-de-Dôme, France
      Centre Jean PERRIN
    Mar 9, 2022

    Vasoconstriction, Vasodilation Trial in Edmonton (Phenylephrine Hydrochloride, Isoproterenol Hydrochloride, Norepinephrine

    Not yet recruiting
    • Vasoconstriction
    • Vasodilation
    • Phenylephrine Hydrochloride
    • +4 more
    • Edmonton, Alberta, Canada
      University of Alberta
    Aug 21, 2023

    Fragile X Syndrome Trial in Barcelona (EGCG, Placebo, Cognitive training)

    Completed
    • Fragile X Syndrome
    • EGCG
    • +2 more
    • Barcelona, Spain
      Parc de Salut MAR, Hospital del Mar Medical Research Institute-I
    May 8, 2019

    Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)

    Not yet recruiting
    • Lobular Breast Carcinoma
    • 68Ga-FAPI-46 PET scan
    • Monaco, Monaco
      Centre Hospitalier Princesse Grace
    Jun 27, 2023

    TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Alkaline Glucosodiene Molecules
    • (no location specified)
    Jul 14, 2023

    Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • Low Grade Serous Adenocarcinoma of Ovary
    • Letrozole tablets
    • carboplatin AUC 5 and paclitaxel 175 mg/m2
    • Brescia, BS, Italy
    • +1 more
    Oct 26, 2022

    Insulin Resistance Trial in Aurora (Estradiol)

    Completed
    Has Results
    • Insulin Resistance
    • Aurora, Colorado
      University of Colorado Denver
    Feb 26, 2021

    Endometrial Tissues and Mononuclear Cells Receptivity in

    Completed
    • Endometrial Hyperplasia Without Atypia
    • +6 more
    • endometrial tissue and peripheral blood mononuclear cells receptivity
    • (no location specified)
    Oct 29, 2023

    Hormonal Contributors to COVID-19 Infection (COV-ENDO)

    Active, not recruiting
    • COVID-19 Pandemic
    • Endocrine System Diseases
    • blood testing
    • Milan, Italy
      Istituto Auxologico Italiano IRCCS
    Mar 6, 2023

    Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy

    Recruiting
    • Advanced Breast Cancer
    • The combination of Dalpiciclib with physician-selected endocrine therapy
    • Chemotherapy selected by the physician
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 22, 2023